Researchers are rapidly examining retatrutide, a novel treatment from Eli Lilly, as a significant step in physique management. Unlike many previous approaches, retatrutide is a dual -action agonist https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide